- Home
- XERS vs DLX Comparison
XERS vs DLX Comparison
Compare XERS & DLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- DLX
- Stock Information
- Founded
- XERS 2005
- DLX 1915
- Country
- XERS United States
- DLX United States
- Employees
- XERS N/A
- DLX N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- DLX Advertising
- Sector
- XERS Health Care
- DLX Consumer Discretionary
- Exchange
- XERS Nasdaq
- DLX Nasdaq
- Market Cap
- XERS 628.7M
- DLX 655.1M
- IPO Year
- XERS 2018
- DLX N/A
- Fundamental
- Price
- XERS $5.01
- DLX $15.74
- Analyst Decision
- XERS Strong Buy
- DLX Strong Buy
- Analyst Count
- XERS 6
- DLX 1
- Target Price
- XERS $6.25
- DLX $23.00
- AVG Volume (30 Days)
- XERS 2.2M
- DLX 371.9K
- Earning Date
- XERS 05-08-2025
- DLX 04-30-2025
- Dividend Yield
- XERS N/A
- DLX 7.62%
- EPS Growth
- XERS N/A
- DLX 61.76
- EPS
- XERS N/A
- DLX 1.24
- Revenue
- XERS $222,551,000.00
- DLX $2,123,277,000.00
- Revenue This Year
- XERS $31.75
- DLX $0.86
- Revenue Next Year
- XERS $21.09
- DLX $1.12
- P/E Ratio
- XERS N/A
- DLX $12.66
- Revenue Growth
- XERS 29.88
- DLX N/A
- 52 Week Low
- XERS $1.72
- DLX $13.70
- 52 Week High
- XERS $6.07
- DLX $24.87
- Technical
- Relative Strength Index (RSI)
- XERS 59.63
- DLX 56.20
- Support Level
- XERS $4.26
- DLX $14.48
- Resistance Level
- XERS $5.28
- DLX $15.98
- Average True Range (ATR)
- XERS 0.28
- DLX 0.59
- MACD
- XERS 0.09
- DLX 0.15
- Stochastic Oscillator
- XERS 78.91
- DLX 65.93
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About DLX Deluxe Corporation
Deluxe Corporation is principally a payments and data company. Its reportable segments are; Merchant Services, B2B Payments, Data Solutions, and Print. Maximum revenue is derived from its Print segment which provides printed personal and business checks, business essentials, as well as branded promotional, print, apparel, and digital storefront solutions. The Merchant Services segment provides electronic credit and debit card authorization, payment systems, and processing services. The B2B segment offers treasury management solutions, integrated accounts payable disbursements, and fraud and security services, and the Data Solutions segment offers data, analytics, and marketing services as well as financial institution profitability reporting and business incorporation services.